Alecensaro reduced the risk of disease recurrence or death by 76% in people with ALK-positive resected non-small cell lung cancer, as demonstrated in the Phase III ALINA study1 ● The approval… Read More
BURLINGTON, NC – Labcorp (NYSE: LH), a leading global life sciences company, announced it has been named a Best Place to Work for Disability Inclusion after earning the top score… Read More
Strategic growth plan execution underway KELOWNA, BC – Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW) (the “Company” or “Lexaria”), a global innovator in drug delivery platforms announces plans for strategic growth. “Lexaria has… Read More
RSV vaccination strongly recommended for Canadians 75 years and older and particularly those with health conditions that put them at higher risk of severe RSV disease RSV vaccination recommended for… Read More
KALAMAZOO, MI – Stryker (NYSE: SYK), a global leader in medical technologies, has completed the previously announced acquisition of Artelon, a privately held company specializing in innovative soft tissue fixation products for… Read More
